Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2012

Oct 26, 2012

30718_dirs_2012-10-26_d649dfcd-c6be-4bf8-9a85-669b94632d52.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2012-10-25

Reporting Person: Nusse Roeland (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-10-25 Stock Option $66.9 A 5000 Acquired 2022-10-24 Common Stock (5000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $70.35 2021-10-26 Common Stock (5000) 5000 Direct
Stock Option $61.46 2020-10-27 Common Stock (5000) 5000 Direct
Stock Option $60.46 2020-05-25 Common Stock (10000) 10000 Direct